| Literature DB >> 20692050 |
Aslaug R Lorentzen1, Espen Melum, Eva Ellinghaus, Cathrine Smestad, Inger-Lise Mero, Jan H Aarseth, Kjell-Morten Myhr, Elisabeth G Celius, Benedicte A Lie, Tom H Karlsen, Andre Franke, Hanne F Harbo.
Abstract
Multiple sclerosis (MS) is an inflammatory, demyelinating disease affecting the central nervous system. MS-associated variants have been reported at both HLA and non-HLA loci, the latter including chromosome 13q31-32 and the Glypican-5 and Glypican-6 genes. In order to further explore the 13q31-32 region in MS, we genotyped 33 SNPs in 1355 Norwegian MS patients and 1446 Norwegian controls. An intronic SNP in the Glypican-5 gene (rs9523787) showed association with MS (p(corr)=0.006). Thus, this study supports that MS susceptibility at 13q31-32 may localize to the Glypican-5 gene, which should lead to further fine-mapping, replication and functional studies of this gene.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20692050 DOI: 10.1016/j.jneuroim.2010.07.003
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478